A personalized cancer vaccine could help prevent melanoma from returning after surgery. Sutter investigators Dr. Kevin Kim, oncologist and chief of precision medicine at Sutter Health, and Dr. Mohammed ...

Adding a personalized mRNA-based cancer vaccine to immunotherapy after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%, according to results from the phase 3 INTerpath-001 ...

Adding a personalized mRNA-based cancer vaccine to immunotherapy after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%, according to results from the phase 3 INTerpath-001 trial presented at the ESMO Congress 2026.